Glomerulonephritis

Glomerulonephritis is a serious inflammatory kidney condition affecting dogs that involves damage to the glomeruli, the microscopic filtering units within the kidneys responsible for removing waste products from the blood while retaining essential proteins and blood cells. When inflammation affects these delicate structures, their filtering function becomes compromised, allowing proteins that should remain in the bloodstream to leak into the urine. This protein loss, combined with ongoing inflammatory damage, can lead to progressive kidney dysfunction and eventually kidney failure if left untreated. Glomerulonephritis represents one of the most common causes of chronic kidney disease in dogs and requires careful, long-term management.

The mechanism underlying glomerulonephritis typically involves the immune system, where antibodies and immune complexes become deposited within the glomerular structures. These immune complexes trigger an inflammatory response that damages the delicate glomerular basement membrane, the specialized filter that normally prevents protein from escaping into urine. In many cases, the immune complexes form in response to chronic infections, autoimmune diseases, or cancer elsewhere in the body, making glomerulonephritis often a secondary condition. The inflammation causes thickening and scarring of glomerular structures, progressively reducing the kidney's ability to filter blood efficiently while simultaneously increasing protein leakage.

The impact of glomerulonephritis on affected dogs varies considerably depending on the severity of glomerular damage and how quickly the condition progresses. Early stages may produce minimal symptoms detectable only through routine blood and urine testing. As protein loss increases, dogs may develop swelling in the legs or abdomen from fluid accumulation, a consequence of low blood protein levels. The ongoing kidney damage can lead to elevated blood pressure, which causes additional harm to the kidneys and other organs. Without treatment, most dogs with significant glomerulonephritis will progress to kidney failure over months to years.

Treatment of glomerulonephritis focuses on reducing inflammation and protein loss while addressing any underlying conditions driving the immune response. Immunosuppressive medications help quiet the inflammatory process, while other treatments target protein loss and manage complications like high blood pressure. Identifying and treating the underlying cause significantly improves outcomes when possible. Dogs diagnosed early and managed appropriately can often maintain good quality of life for extended periods, though the condition typically requires lifelong monitoring and treatment. Working with a veterinarian experienced in kidney disease management is essential for optimizing outcomes.

The primary cause of glomerulonephritis in dogs is immune complex deposition within the glomeruli, where antibodies bound to antigens become trapped in the filtering structures and trigger inflammation. This process can occur when the immune system responds to chronic infections, cancer, or autoimmune diseases, producing large quantities of antibodies that form complexes with circulating antigens. These immune complexes deposit in the glomeruli due to the unique blood flow characteristics and filtering function of these structures. Once deposited, the complexes activate inflammatory pathways that damage the glomerular basement membrane and supporting cells.

Chronic infectious diseases represent the most commonly identified underlying causes of glomerulonephritis in dogs. Heartworm disease, with its chronic antigenic stimulation from parasites living in the heart and blood vessels, frequently causes glomerular damage through immune complex deposition. Tick-borne diseases including ehrlichiosis, anaplasmosis, and Lyme disease can similarly trigger immune complex formation. Chronic bacterial infections such as pyometra, dental disease, skin infections, and prostatitis provide ongoing antigenic stimulation that may result in glomerulonephritis. Chronic viral infections and fungal diseases have also been associated with glomerular immune complex disease.

Autoimmune and inflammatory conditions predispose dogs to developing glomerulonephritis through several mechanisms. Systemic lupus erythematosus, a multi-organ autoimmune disease, commonly affects the kidneys through immune complex deposition. Inflammatory bowel disease and chronic pancreatitis generate ongoing immune activation that can secondarily affect the kidneys. Some breeds appear genetically predisposed to developing autoimmune glomerulonephritis, suggesting inherited factors that influence immune regulation or glomerular structure. In many cases, despite thorough diagnostic investigation, no underlying cause can be identified, and the condition is classified as idiopathic glomerulonephritis.

Neoplastic diseases, or cancers, can trigger glomerulonephritis through production of abnormal proteins or chronic antigenic stimulation from tumor cells. Lymphoma, multiple myeloma, and various carcinomas have been associated with secondary glomerular disease. The tumor produces antigens that combine with antibodies, forming immune complexes that deposit in the kidneys. Additionally, some cancers produce abnormal proteins that directly damage glomerular structures or alter blood flow within the kidneys. Detecting underlying cancer is important in older dogs presenting with glomerulonephritis, as treatment of the primary tumor may improve kidney function.

The mechanism by which glomerular damage occurs involves activation of inflammatory cells and release of damaging molecules within the glomerular structures. Once immune complexes deposit, they activate complement proteins and attract inflammatory cells including neutrophils and macrophages. These cells release enzymes and reactive oxygen species that damage glomerular cells and the basement membrane. Over time, repeated injury leads to scarring and replacement of functional glomeruli with fibrous tissue. The remaining healthy nephrons work harder to compensate, eventually becoming damaged themselves through a process called hyperfiltration injury. This progressive loss of functional kidney tissue explains why glomerulonephritis often leads to chronic kidney disease even when the initial inflammatory process is controlled.

Early warning signs of glomerulonephritis are often subtle and may be absent entirely in the initial stages of the disease. The condition frequently develops silently, with protein loss into the urine being the only detectable abnormality for months before other symptoms appear. Some owners notice their dog drinking slightly more water than usual or urinating more frequently, though these changes may be mild enough to escape notice. Changes in coat quality, with the fur becoming dull or rough, can occur due to protein loss affecting skin and hair health. Weight loss may be gradual and attributed to other causes before kidney disease is suspected.

Common symptoms of more advanced glomerulonephritis relate to the consequences of ongoing protein loss and declining kidney function. Lethargy and decreased energy are frequently observed as protein depletion affects muscle mass and overall body function. Decreased appetite may develop, though it is often intermittent initially. Dogs may show subtle changes in their usual behavior, seeming less enthusiastic about activities they previously enjoyed. Nausea and occasional vomiting may occur as kidney function declines and waste products accumulate in the bloodstream.

Behavioral changes in dogs with glomerulonephritis often reflect how they feel physically as the disease progresses. Dogs may become less playful and more withdrawn, preferring to rest rather than engage in normal activities. Changes in drinking and urination patterns typically become more pronounced, with dogs drinking noticeably larger volumes of water and producing larger amounts of dilute urine. Some dogs develop a picky appetite, showing interest in food but eating less than usual. Restlessness or difficulty settling may indicate nausea or general discomfort related to the metabolic effects of kidney dysfunction.

Physical signs of glomerulonephritis become more apparent as the disease advances. Peripheral edema, or swelling of the legs and feet, occurs when protein loss becomes severe enough to reduce blood oncotic pressure, allowing fluid to leak from blood vessels into surrounding tissues. Abdominal distension from fluid accumulation, called ascites, may develop in severely affected dogs. Weight loss and muscle wasting become visible as the body catabolizes muscle tissue to compensate for protein losses. Dogs with concurrent high blood pressure may develop sudden blindness from retinal detachment or show neurological signs if blood pressure becomes dangerously elevated.

Symptom progression in glomerulonephritis varies depending on the underlying cause and response to treatment. Some dogs experience a relatively slow progression over many months, while others decline more rapidly. Worsening appetite, increased vomiting, and progressive lethargy typically indicate advancing kidney disease. Bad breath from uremia develops as the kidneys lose their ability to remove waste products. Changes in urination may include decreased urine production as the kidneys fail or continued high-volume dilute urine if concentrating ability is preferentially lost.

Emergency symptoms requiring immediate veterinary attention include sudden collapse, severe difficulty breathing from fluid accumulation in the lungs or chest cavity, sudden blindness, seizures, or complete inability to urinate. Dogs showing signs of blood clots, including sudden leg paralysis or severe pain, need urgent evaluation as glomerulonephritis increases the risk of thromboembolism. Profound lethargy, unresponsiveness, or inability to stand warrant emergency care. Any rapid worsening of previously stable symptoms should prompt immediate veterinary consultation to assess for crisis complications of the disease.

Initial examination for suspected glomerulonephritis includes a comprehensive physical assessment and detailed discussion of the dog's history. The veterinarian evaluates hydration status, checks for edema in the legs and abdomen, assesses body condition and muscle mass, and listens to the heart and lungs. Blood pressure measurement is an important component of the examination, as hypertension commonly accompanies glomerular disease. The veterinarian inquires about changes in appetite, water consumption, urination patterns, energy level, and any other symptoms the owner has observed. A thorough history helps identify potential underlying causes that may be driving the immune process.

Diagnostic testing for glomerulonephritis begins with blood and urine analysis to assess kidney function and detect protein loss. A complete blood count may reveal anemia, which commonly develops in chronic kidney disease. Blood chemistry evaluates kidney function markers including blood urea nitrogen, creatinine, and symmetric dimethylarginine, while also assessing electrolytes and protein levels. Urinalysis examines urine concentration, looks for blood or inflammatory cells, and screens for protein. The urine protein to creatinine ratio provides a quantitative measure of protein loss that helps stage the severity of glomerular disease and monitor response to treatment.

Differentiating glomerulonephritis from other causes of proteinuria and kidney disease requires systematic evaluation. Other kidney diseases, urinary tract infections, and even some normal variations can cause protein in the urine. The veterinarian evaluates urine sediment for signs of infection or inflammation that might suggest alternative causes. Testing for underlying infectious diseases that commonly cause glomerulonephritis, including heartworm, tick-borne diseases, and leptospirosis, helps identify treatable conditions. Imaging studies including abdominal ultrasound evaluate kidney size, structure, and appearance while also looking for evidence of underlying conditions elsewhere in the body.

Confirmation of glomerulonephritis diagnosis ideally involves kidney biopsy, which allows direct examination of glomerular tissue under the microscope. Biopsy differentiates glomerulonephritis from other causes of proteinuria and provides information about the type and severity of glomerular damage. Special staining techniques and electron microscopy can identify immune complex deposits and characterize the specific pattern of injury. However, kidney biopsy carries risks including bleeding and is not always recommended depending on the dog's overall condition and likely benefit from the information obtained. Many dogs are managed based on clinical findings and response to treatment without definitive biopsy diagnosis.

Emergency treatment for dogs presenting with severe complications of glomerulonephritis addresses immediately life-threatening issues first. Dogs with significant fluid accumulation in the lungs or abdomen may require therapeutic drainage to improve breathing and comfort. Severely hypertensive dogs need medications to lower blood pressure rapidly and prevent organ damage. Acute thromboembolism requires anticoagulant therapy and supportive care. Dogs in acute kidney failure need intravenous fluid therapy and potentially dialysis if available. Stabilization allows subsequent diagnostic evaluation and initiation of longer-term management strategies.

Medical management of glomerulonephritis targets multiple aspects of the disease process to reduce protein loss, control inflammation, and protect remaining kidney function. Immunosuppressive medications including mycophenolate, cyclosporine, or corticosteroids help reduce glomerular inflammation in many cases. The specific immunosuppressive chosen depends on biopsy findings if available, suspected underlying cause, and the dog's overall health status. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers reduce protein loss through the kidneys and provide additional blood pressure lowering effects. Low-dose aspirin may be prescribed to reduce the risk of blood clot formation.

Surgical intervention is not typically part of glomerulonephritis treatment since the condition involves diffuse inflammation throughout both kidneys rather than a localized structural problem. However, if an underlying condition that could be surgically corrected is identified as driving the glomerulonephritis, addressing that condition may improve kidney outcomes. For example, removing an infected uterus in pyometra or addressing a chronic abscess eliminates the ongoing antigenic stimulation. Treatment of heartworm disease, while not surgical, removes a common underlying cause. Dental extractions and treatment of other chronic infections may similarly help by reducing immune complex formation.

Supportive care for dogs with glomerulonephritis includes dietary management and treatment of secondary complications. Prescription kidney diets typically contain reduced but high-quality protein, restricted phosphorus, added omega-3 fatty acids, and enhanced B vitamins. These diets help reduce the kidney's workload while providing adequate nutrition. Phosphorus binders may be added if blood phosphorus levels remain elevated despite dietary restriction. Anti-nausea medications help maintain appetite. Fluid therapy, either intravenous or subcutaneous, may be needed periodically for dogs who become dehydrated.

Alternative and complementary treatments may support overall health in dogs with glomerulonephritis, though they should not replace conventional medical management. Omega-3 fatty acid supplementation from fish oil has anti-inflammatory properties and may help reduce proteinuria. Some veterinarians recommend antioxidant supplements to protect remaining kidney tissue from oxidative damage. Acupuncture has been used to support kidney function and overall wellbeing in dogs with chronic kidney disease. Herbal preparations marketed for kidney support should be used cautiously and only with veterinary approval, as some herbs may actually be harmful to compromised kidneys.

Treatment decision factors include the severity of disease, presence and treatability of underlying causes, the dog's overall health and age, and owner factors including ability to administer medications and afford long-term treatment. Dogs with mild proteinuria and normal kidney function may do well with conservative management including ACE inhibitors and dietary modification alone. More severe cases typically require immunosuppressive therapy, which increases costs and requires more intensive monitoring. Discussing prognosis, expected treatment intensity, and quality of life considerations helps owners make informed decisions about pursuing treatment for their individual dog.

Recovery expectations for dogs with glomerulonephritis vary considerably depending on the severity of disease at diagnosis, the underlying cause, and response to treatment. Dogs whose glomerulonephritis is secondary to a treatable underlying condition, such as heartworm disease or a chronic infection, often show significant improvement once the primary problem is addressed. Idiopathic glomerulonephritis, where no underlying cause is identified, typically requires ongoing management but can often be controlled for extended periods. Complete cure of glomerulonephritis is uncommon, but stabilization of protein loss and preservation of kidney function are achievable goals in many cases.

Post-treatment care for glomerulonephritis involves long-term medication administration, dietary management, and regular monitoring. Most dogs require lifelong treatment with some combination of immunosuppressive and kidney-protective medications. The specific medications and doses are adjusted based on ongoing monitoring of proteinuria levels and kidney function. Activity restrictions are generally not needed for stable dogs, though avoiding excessive heat, strenuous exercise, and dehydration helps protect kidney function. Owners should be educated about signs of disease progression or complications that warrant prompt veterinary attention.

Prognostic factors for dogs with glomerulonephritis include the degree of proteinuria at diagnosis, kidney function status, presence of complications like hypertension or thromboembolism, and the response to treatment over the first few months. Dogs with mild to moderate proteinuria and normal kidney function at diagnosis generally have a better prognosis than those presenting with severe protein loss or already elevated kidney values. The ability to identify and treat an underlying cause improves prognosis. Dogs who show significant reduction in proteinuria on treatment typically survive longer than those whose protein loss remains poorly controlled despite therapy.

Long-term outlook for dogs with managed glomerulonephritis varies from months to years depending on the factors mentioned above. Studies suggest that dogs with well-controlled proteinuria can live for one to three years or longer after diagnosis, with some dogs surviving much longer. However, progression to chronic kidney disease and eventually kidney failure occurs in many dogs despite treatment, particularly as they age. Regular monitoring allows early detection of disease progression so that treatment adjustments can be made. Maintaining open communication with the veterinary team helps ensure the dog receives optimal care throughout the course of disease.

Primary prevention of glomerulonephritis focuses on avoiding and promptly treating the infections and conditions that commonly trigger glomerular immune complex disease. Keeping dogs current on heartworm prevention eliminates one of the most common underlying causes. Prompt treatment of tick-borne diseases when detected, and use of tick preventatives in endemic areas, reduces this risk factor. Maintaining good dental health through regular dental care and addressing dental disease when present eliminates a common source of chronic infection. Timely spaying of female dogs prevents pyometra, another infection associated with glomerulonephritis.

Breeding recommendations for glomerulonephritis are complicated by the typically multifactorial nature of the condition. However, breeds with documented high prevalence of hereditary glomerulonephritis should have breeding dogs screened through urine protein testing before breeding. The Soft Coated Wheaten Terrier Club and other breed organizations have established screening protocols for protein-losing nephropathy. Affected dogs and their close relatives should not be bred. Purchasing puppies from breeders who follow health screening recommendations reduces the risk of acquiring a dog predisposed to this condition.

Nutritional prevention strategies are not well established for glomerulonephritis, though maintaining overall health through balanced nutrition supports immune function and kidney health. Avoiding obesity reduces general health risks and may decrease inflammatory burden. Some evidence suggests that omega-3 fatty acid supplementation may have protective effects on kidney health, though this has not been definitively proven to prevent glomerulonephritis. Ensuring adequate hydration by always providing fresh water supports kidney function. Avoiding known nephrotoxins in foods and environment protects kidney health generally.

Regular veterinary care enables early detection of problems before they progress to clinical disease. Annual wellness examinations with blood and urine screening can detect proteinuria before symptoms develop, allowing earlier intervention. For breeds predisposed to glomerulonephritis, more frequent screening may be recommended. Maintaining vaccination against infectious diseases that can trigger kidney damage provides additional protection. Discussing any family history of kidney disease with the veterinarian ensures appropriate monitoring for at-risk dogs.

Early intervention when proteinuria is detected on routine screening significantly improves outcomes compared to waiting until symptoms develop. Low-level proteinuria detected incidentally should prompt investigation for underlying causes and monitoring for progression. Starting kidney-protective medications like ACE inhibitors early in the disease course may slow progression. Dietary modification to moderate protein and supplement omega-3 fatty acids can be implemented before kidney function declines. Dogs with early glomerular disease who receive prompt treatment often have much better long-term outcomes than those diagnosed after significant kidney damage has already occurred.

Daily management of a dog with glomerulonephritis centers on consistent medication administration and monitoring for changes in condition. Most dogs require multiple medications given once or twice daily, and establishing a reliable routine helps ensure doses are not missed. Some immunosuppressive medications must be given with food while others require fasting administration, so understanding the specific requirements for each medication is important. Fresh water should always be available, and monitoring daily water intake helps track disease stability. Recording any symptoms, appetite changes, or behavioral observations in a daily log provides valuable information for veterinary visits.

Home environment modifications for dogs with glomerulonephritis are generally minimal unless complications have developed. Dogs with significant edema or ascites may benefit from elevated food and water bowls and soft bedding that does not put pressure on swollen areas. If weakness or balance issues develop from severe protein loss, removing obstacles and providing non-slip surfaces helps prevent injuries. Temperature regulation becomes more important as kidney disease progresses, so ensuring the dog has access to comfortable temperatures without becoming overheated or chilled supports wellbeing. Stress reduction through maintaining familiar routines and minimizing disruptions benefits overall health.

Quality of life for dogs with well-managed glomerulonephritis can remain good for extended periods. Most dogs continue to enjoy their normal activities, relationships, and routines while on treatment. Focus on activities the dog enjoys and can comfortably participate in rather than dwelling on restrictions. Mental stimulation through gentle play, training, and social interaction keeps dogs engaged. Many owners find that their dogs do not seem to realize they are ill and continue to find joy in everyday experiences. Regular assessment of quality of life through standardized scales helps ensure treatment continues to provide net benefit to the dog.

Monitoring and ongoing care requirements include regular veterinary visits with blood and urine testing to assess treatment effectiveness and disease stability. Initially, monitoring may be needed every few weeks as medications are adjusted. Once stable, visits every two to four months are typical, with more frequent checks if problems develop. Blood pressure monitoring ensures hypertension remains controlled. Weight checks help track muscle mass and fluid status. Owners should watch for signs of disease progression including increased lethargy, decreased appetite, vomiting, or visible swelling, and contact the veterinarian promptly if these develop.

Caregiver support resources help owners manage the emotional and practical challenges of caring for a dog with chronic kidney disease. Online communities and breed-specific groups connect owners facing similar challenges. Financial assistance programs may help offset treatment costs for qualifying families. Discussing quality of life expectations, prognosis, and end-of-life planning with the veterinary team helps owners make informed decisions throughout the disease course. Recognizing that providing excellent care for a chronically ill pet is emotionally demanding, and seeking support when needed, helps owners maintain their own wellbeing while caring for their dog.

Soft Coated Wheaten Terriers have the highest documented prevalence of hereditary glomerulonephritis among dog breeds, with the condition representing a significant health concern in this breed. The disease in Wheatens is part of a protein-losing nephropathy and enteropathy complex that affects both kidneys and intestines. Onset typically occurs in middle age, though earlier presentation is possible. The Soft Coated Wheaten Terrier Club of America has established health testing protocols and maintains a database tracking affected dogs. Responsible breeders screen breeding dogs annually and exclude affected dogs and their close relatives from breeding programs.

Several other breeds demonstrate increased susceptibility to glomerulonephritis compared to the general dog population. Bernese Mountain Dogs have documented hereditary glomerulonephritis with onset typically in young adults. English Cocker Spaniels, Samoyeds, and Bull Terriers have all been reported with familial glomerular disease. Doberman Pinschers and Rottweilers may have increased risk compared to mixed breed dogs. Shar-Peis are predisposed to a familial renal amyloidosis that can present similarly to glomerulonephritis. The genetic basis has not been fully characterized for most of these breeds, limiting the availability of screening tests.

Screening recommendations for breeds at risk of glomerulonephritis emphasize regular urine testing to detect proteinuria before clinical symptoms develop. Annual urine protein to creatinine ratio testing is recommended for Soft Coated Wheaten Terriers starting at age two and continuing throughout life. Similar testing is advisable for other predisposed breeds. Breeding dogs should be tested before each breeding and dogs with elevated protein levels should not be bred. Puppy buyers should request documentation of health testing from breeders and verify results through breed club health registries when available. Working with veterinarians familiar with breed-specific health concerns ensures appropriate monitoring protocols are followed.

Protein-losing enteropathy commonly co-occurs with glomerulonephritis, particularly in Soft Coated Wheaten Terriers where both conditions represent manifestations of a single hereditary disease complex. When both the kidneys and intestines lose protein, affected dogs experience more severe consequences including profound edema, weight loss, and nutrient deficiencies. Diagnosis requires testing both kidney and intestinal function, and treatment must address both organ systems. Dogs with concurrent protein-losing nephropathy and enteropathy generally have a more guarded prognosis than those with kidney involvement alone.

Conditions with similar symptoms to glomerulonephritis include other forms of chronic kidney disease, amyloidosis, and other protein-losing kidney diseases. Amyloidosis involves deposition of abnormal amyloid proteins in the kidneys rather than immune complexes but can present with similar proteinuria and progressive kidney dysfunction. Tubular kidney diseases affect different structures than glomerulonephritis but may cause some overlapping symptoms. Lower urinary tract disease can cause blood and protein in urine that must be distinguished from glomerular protein loss. Accurate diagnosis through appropriate testing ensures dogs receive the most effective treatment for their specific condition.

Potential complications of glomerulonephritis include thromboembolic disease, where blood clots form due to loss of anticoagulant proteins and changes in clotting factor balance. These clots can lodge in major blood vessels causing sudden paralysis, difficulty breathing, or organ dysfunction depending on location. Systemic hypertension develops in many dogs with glomerulonephritis and can cause blindness from retinal detachment, stroke-like episodes, or accelerated kidney damage. Severe edema and fluid accumulation can impair breathing and mobility. Progression to end-stage kidney disease requiring dialysis or resulting in death occurs in many dogs despite treatment. Understanding these potential complications helps owners recognize warning signs that warrant urgent veterinary attention.